verified SJR 0,565 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · Wiley-Blackwell Publishing L...

workspace_premium Q2 — Medicine (miscellaneous) lock_open Open Access

Vox Sanguinis

Vox Sanguinis is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 96. It has a price of 2750 €. It has an SJR impact factor of 0,565 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,565.

Vox Sanguinis focuses its scope in these topics and keywords: blood, plasma, red, leukocytes, virus, cell, g, chromatographic, predict, antibody, ...

ISSN: 0042-9007

Publisher: Wiley-Blackwell Publishing Ltd

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,565 Q2

H-index 96

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.750 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,565

H-index

Docs (year)

170

Docs 3y

471

Total refs

4572

Cites 3y

741

Citable 3y

407

Cites/Doc 2y

1.46

Ref/Doc

26.89

Immediate OA

2750 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Capillary and venous haemoglobin levels in blood donors: a 42-month study of 36 258 paired samples

Viral Safety of Blood Derivatives by Immune Neutralization

Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical use

Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001

Establishment and Organization

Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines

Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections

Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII

Creutzfeldt-Jakob disease and blood transfusion safety

Clinical Aspects and Typing of Platelet Alloantigens

Chagas' disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank

Chagas' Disease and Blood Transfusion:

SHOW MORE ARTICLES

Cellular Therapy: New Frontiers in Transfusion Medicine

24-hour 51Cr post-transfusion survival, 51Cr life span and haemolysis of red blood cells stored at 4 oC for 56 days in AS-3

Blue-blooded or cherry-blooded: what's in the colour?

Automated blood-mixing devices still fail to mix at low bleeding rates

Autologous blood donation and transfusion in Europe

Author's reply

Anti-GOR without Anti-HCV Core Is Not Associated with Hepatitis C Viremia

A Second Outbreak of Hepatitis C Virus Infection from Anti-D Immunoglobulin in Ireland

A novel simple assay system for the detection of human platelet antigen 15 (HPA-15) alloantibodies based on three techniques: an HPA-15 expressing cell line, a monoclonal antibody-specific antigen-capture method and mixed-passive haemagglutination

A multicentre evaluation of a new filtration protocol for leucocyte depletion of high-haematocrit red blood cells collected by an automated blood collection system

A global standard for anti-D immunoglobulin: international collaborative study to evaluate a candidate preparation

FAQs

Vox Sanguinis has an SJR of 0,565 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2750 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Vox Sanguinis is 26%.

Vox Sanguinis

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Vox Sanguinis?

What is the APC / publication cost?

What is the acceptance rate?